Equities

Fancl Corp

Fancl Corp

Actions
Consumer DiscretionaryPersonal Goods
  • Price (JPY)2,759.50
  • Today's Change39.50 / 1.45%
  • Shares traded1.08m
  • 1 Year change+11.77%
  • Beta0.8959
Data delayed at least 20 minutes, as of Jul 22 2024 07:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

FANCL CORPORATION is a Japan-based company principally engaged in the research, development, manufacture and sale of cosmetics and dietary supplements. The Company operates in three business segments. Cosmetics segment is involved in the manufacture and sale of cosmetics, as well as the supply of original equipment manufacturer (OEM). Dietary Supplement Related segment manufactures and sells dietary supplements. Others segment provides miscellaneous goods, underwear, accessories, germinated rice and green juice (aojiru).

  • Revenue in JPY (TTM)110.88bn
  • Net income in JPY8.83bn
  • Incorporated1982
  • Employees1.28k
  • Location
    Fancl CorpFANCL Bldg.89-1, Yamashita-cho, Naka-kuYOKOHAMA-SHI 231-8528JapanJPN
  • Phone+81 452261200
  • Websitehttps://www.fancl.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Milbon Co Ltd48.93bn4.09bn110.41bn1.14k26.512.3817.312.26125.78125.781,503.701,401.820.9431.9410.7542,920,920.007.8910.079.0111.7561.3664.698.3611.332.44--0.0049.235.586.30-28.25-2.3019.1310.26
Earth Corp159.57bn3.74bn111.72bn4.79k29.721.6313.260.7001169.25169.257,213.123,084.551.092.654.5733,327,900.002.793.865.917.7440.1539.752.552.540.7614--0.159857.963.94-2.65-22.65--22.660.5164
Arata Corp944.15bn10.32bn128.73bn2.89k12.011.108.610.1363297.19297.1927,273.553,252.273.1120.217.63326,356,400.003.403.197.436.889.799.971.100.99371.16152.720.259325.185.894.5925.538.3811.6718.25
Pigeon Corp94.60bn6.89bn183.09bn3.62k26.122.3315.171.9457.6257.62790.95645.990.92963.125.3326,146,210.006.8910.058.5512.4348.2148.797.419.953.35--0.0093.82-0.4846-2.05-13.49-12.210.94672.25
Noevir Holdings Co Ltd63.28bn7.60bn198.11bn1.37k26.074.1022.403.13222.45222.451,852.691,413.880.84852.466.2946,258,040.0010.368.7212.459.8867.9366.0612.2112.213.11--0.0175103.982.301.581.11-0.4348-4.224.10
PALTAC Corp1.15tn20.64bn271.85bn2.24k13.140.975610.000.236328.39328.3918,329.984,422.862.3720.775.62514,960,200.004.244.697.408.397.507.681.791.941.43--0.002423.994.332.567.200.8661-10.836.69
Pola Orbis Holdings Inc172.05bn10.05bn319.76bn4.05k30.761.8817.781.8645.3745.37776.86741.320.85431.9110.2942,524,470.005.025.375.846.1882.0882.845.886.272.91--0.0003124.314.21-6.96-15.562.8712.16-8.25
Fancl Corp110.88bn8.83bn355.47bn1.28k37.484.1027.633.2172.7672.76913.41665.821.033.018.6286,897,340.008.237.9810.379.6366.9168.587.977.002.04--0.112152.357.03-1.9777.730.4219-7.932.53
Lion Corp404.88bn16.59bn372.32bn7.55k22.381.329.420.919658.5058.501,428.21989.970.87943.576.1053,626,760.004.135.636.058.9345.3447.604.706.451.17--0.100231.013.312.88-33.34-10.609.215.39
Kobayashi Pharmaceutical Co Ltd176.47bn17.71bn438.56bn3.53k24.032.0418.152.49233.81233.812,340.202,757.180.68653.134.9049,935,770.006.898.018.5310.1855.5356.4510.0312.242.19--0.004633.194.330.70371.582.4529.678.88
Kose Corp309.83bn14.71bn615.62bn7.56k39.412.1423.371.99257.80257.805,430.204,757.500.85221.226.5840,993,780.004.32--5.56--70.42--5.06--2.70--0.0357--3.90---37.87------
Data as of Jul 22 2024. Currency figures normalised to Fancl Corp's reporting currency: Japanese Yen JPY

Institutional shareholders

17.70%Per cent of shares held by top holders
HolderShares% Held
MY.Alpha Management (HK) Advisors Ltd.as of 18 Jul 202410.34m7.94%
Nomura Asset Management Co., Ltd.as of 14 Apr 20233.81m2.92%
The Vanguard Group, Inc.as of 04 Jul 20242.35m1.80%
Nikko Asset Management Co., Ltd.as of 05 Jul 20241.30m0.99%
Daiwa Asset Management Co. Ltd.as of 28 Jun 20241.28m0.98%
Norges Bank Investment Managementas of 31 Dec 20231.17m0.90%
BlackRock Fund Advisorsas of 04 Jul 20241.06m0.81%
Dimensional Fund Advisors LPas of 04 Jul 2024898.90k0.69%
Mitsubishi UFJ Asset Management Co., Ltd.as of 05 Jul 2024534.10k0.41%
BlackRock Japan Co. Ltd.as of 04 Jul 2024346.30k0.27%
More ▼
Data from 31 Dec 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.